| # | Drug | Count |
|---|---|---|
| 0 | BUPRENORPHINE | 1026 |
| 1 | NICOTINE | 309 |
| 2 | ESTRADIOL | 290 |
| 3 | MINOXIDIL | 147 |
| 4 | DICLOFENAC SODIUM | 116 |
| 5 | MINOXIDIL FOAM 5% (WOMENS) | 116 |
| 6 | NICOTINE POLACRILEX | 106 |
| 7 | METHYLPHENIDATE | 103 |
| 8 | GABAPENTIN | 100 |
| 9 | FENTANYL | 96 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZALKONIUM CHLORIDE (0.115%) | 2 | 1.0000 |
| 1 | CAMPHOR, MENTHOL, AND MEHTYL SALICYLATE | 1 | 0.5000 |
| 2 | AVOBENZONE, OCTISALATE, OCTOCRYLENE, HOMOSALATE | 1 | 0.5000 |
| 3 | CANTHARIDIN | 78 | 0.4262 |
| 4 | MENTHOL 0.80% | 1 | 0.3333 |
| 5 | METHYL NICOTINATE, CAPSAICIN | 1 | 0.3333 |
| 6 | 1% HYDROCORTISONE | 1 | 0.2500 |
| 7 | MENTHOL 10.5% | 1 | 0.2500 |
| 8 | CAPSACIN | 1 | 0.2000 |
| 9 | MENTHOL, CAMPHOR | 1 | 0.1429 |
| # | Drug class | Count |
|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 1026 |
| 1 | Cholinergic Nicotinic Agonist [EPC] | 379 |
| 2 | Estrogen [EPC] | 354 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 212 |
| 4 | Arteriolar Vasodilator [EPC] | 163 |
| 5 | Benzodiazepine [EPC] | 138 |
| 6 | Opioid Agonist [EPC] | 136 |
| 7 | Central Nervous System Stimulant [EPC] | 124 |
| 8 | 5-alpha Reductase Inhibitor [EPC] | 123 |
| 9 | Central alpha-2 Adrenergic Agonist [EPC] | 120 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 1026 | 0.0109 |
| 1 | Monoamine Oxidase Inhibitor [EPC] | 27 | 0.0087 |
| 2 | Cholinergic Nicotinic Agonist [EPC] | 379 | 0.0062 |
| 3 | Nonergot Dopamine Agonist [EPC] | 91 | 0.0058 |
| 4 | Aryl Hydrocarbon Receptor Agonist [EPC] | 9 | 0.0046 |
| 5 | Provitamin D2 Compound [EPC] | 88 | 0.0030 |
| 6 | Central alpha-2 Adrenergic Agonist [EPC] | 120 | 0.0022 |
| 7 | Arteriolar Vasodilator [EPC] | 163 | 0.0021 |
| 8 | Estrogen [EPC] | 354 | 0.0019 |
| 9 | Cholinesterase Inhibitor [EPC] | 36 | 0.0019 |